It has been demonstrated that transgenic alteration of Cacna1g expression acts as a modifier of epilepsy in the Scn2aQ54 mouse model of focal epilepsy, with elevated levels of Cacna1g increasing spontaneous seizure frequency, whereas reduced Cacna1g diminishing seizures [36]. This evidence concerns the gene CACNA1G and epilepsy.